Abstracts Archive - Page 1815 of 2425 - ACR Meeting Abstracts

Abstract Number: 1890 • 2015 ACR/ARHP Annual Meeting
Subclinical Biventricular Systolic Function Is Impaired in Patients with Systemic Sclerosis with Real Time 3-D Echpcardiography: 1 Year Follow-up Study
Sule Yavuz¹, Taylan Sahin², Selen Yurdakul², Neslihan Yilmaz³ and Saide Ertekin⁴, ¹Rheumatology, Istanbul Bilim University, Faculty of Medicine,Department of Rheumatology, Istanbul, Turkey, ²Cardiology, Istanbul Bilim University Dept of Cardiology, Istanbul, Turkey, ³Istanbul Bilim University, Faculty of Medicine, Rheumatology Department, Istanbul, Turkey, ⁴Cardiology, Istanbul Bilim University, Dept of Cardiology, Istanbul, Turkey
Background/Purpose: Silent myocardial involvement is associated with poor prognosis in patients with systemic sclerosis (SSc). Here, we aimed to evaluate subclinical left ventricular (LV) and…
Abstract Number: 1891 • 2015 ACR/ARHP Annual Meeting
Parameters That Predict Worsening of Skin Thickness in Patients with Early Diffuse Cutaneous Systemic Sclerosis
Masataka Kuwana¹, Minoru Hasegawa², Yucihiro Shirai¹, Osamu Ishikawa³, Hirahito Endo⁴, Fumihide Ogawa⁵, Daisuke Goto⁶, Shinichi Sato⁷, Hironobu Ihn⁸, Yasushi Kawaguchi⁹ and Kazuhiko Takehara¹⁰, ¹Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan, ²Dermatology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan, ³Department of Dermatology, Gunma University Graduate School of Medicine, Gunma, Japan, ⁴Department of Rheumatology, Jusendo General Hospital, Koriyama, Japan, ⁵Department of Dermatology, Nagasaki University Graduate School of Biomedical Science, Nagasaki, Japan, ⁶Division of Clinical Immunology, Doctoral Program in Clinical Sciences, University of Tsukuba, Graduate School of Comprehensive Human Sciences, Tsukuba, Japan, ⁷Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan, ⁸Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan, ⁹Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ¹⁰Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa City, Japan
Background/Purpose: Skin thickness is a hallmark of systemic sclerosis (SSc), and its progression is associated with poor prognosis. The modified Rodnan total skin thickness score…
Abstract Number: 1892 • 2015 ACR/ARHP Annual Meeting
Impact of Cardiac Magnetic Resonance Imaging with T1 Mapping and Multi-b Value Diffusion-Weighted Sequences in Systemic Sclerosis for the Assessment of Myocardial Microscopic Fibrosis and Perfusion
Benjamin Terrier¹, Hervé Gouya², Alice Berezne¹, Alexis Regent³, Pascal Cohen¹, Loïc Guillevin⁴, Claire Le Jeunne⁵, Paul Legmann², Olivier Vignaux⁶ and Luc Mouthon⁷, ¹Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Paris, France, ²AP-HP Cochin Hospital, Department of Radiology B, Paris, France, ³Service de médecine interne, Hôpital Cochin, Paris, France, ⁴Internal Medicine, Hopital Cochin, Paris, France, ⁵Department of Internal Medicine, Hotel-Dieu Hospital, AP-HP, Paris, Paris, France, ⁶Radiology, Cochin University Hospital, Paris, France, ⁷Department of Internal Medicine, Department of Internal Medicine, Cochin Hospital, Referent Center for Necrotizing Vasculitis and Systemic Sclerosis, Paris-Descartes University, AP-HP, Paris, France
Background/Purpose: Systemic sclerosis (SSc) is a complex disease associating vasculopathy, cutaneous and visceral fibrosis, and autoimmunity. Myocardial microscopic fibrosis may occur and potentially lead to…
Abstract Number: 1893 • 2015 ACR/ARHP Annual Meeting
Relationship Between Vitamin D Levels and Disease Activity in Patients with Systemic Sclerosis
Julia Romero¹, Amalia Schiel², Mariana Landa², María Luisa Díaz³, María Eugenia Lara¹, Mariano Rivero⁴, Marina Khoury⁵, Mirtha Alonso² and Juan Carlos Barreira¹, ¹Rheumatology Service, British Hospital, Buenos Aires, Argentina, ²Central Laboratory, British Hospital, Buenos Aires, Argentina, ³Nuclear Medicine, British Hospital, Buenos Aires, Argentina, ⁴Rheumatolgy Service, British Hospital, Buenos Aires, Argentina, ⁵Teaching and Research, British Hospital, Buenos Aires, Argentina
Background/Purpose: Low Vitamin D (VD) levels have been observed in several autoimmune diseases, including systemic sclerosis (SSc). Some studies have shown the importance of VD…
Abstract Number: 1894 • 2015 ACR/ARHP Annual Meeting
Calcium Channel Blockers Are More Effective in the Treatment of Primary Raynaud’s Phenomenon Compared to Secondary: A Meta-Analyis
Janet E. Pope¹, Fadumo Rirash², Paul Tingey³, Sarah Harding⁴, Lara J. Maxwell⁵, Peter Tugwell⁶, Jordi Pardo⁷, Elizabeth Ghogomu⁸ and George A. Wells⁹, ¹University of Western Ontario, London, ON, Canada, ²Medicine/Rheumatology, University of Western Ontario, London, ON, Canada, ³Faculty of Medicine, University of Queensland, Brisbane, Australia, ⁴ERLanger, ERLanger, KY, ⁵Centre for Global Health, Institute of Population Health, University of Ottawa, Ottawa, ON, Canada, ⁶Center For Global Health, Institute of Population Hlth, Ottawa, ON, Canada, ⁷University of Ottawa, Ottawa, ON, Canada, ⁸University of Ottawa, Cochrane Musculoskeletal Group, Ottawa, ON, Canada, ⁹Cardiovascular Research Reference Centre, University of Ottawa Heart Institute, Ottawa, ON, Canada
Background/Purpose: To assess the benefits and harms of calcium channel blockers (CCBs) versus placebo for the treatment of Raynaud's phenomenon (RP) comparing primary to secondary…
Abstract Number: 1895 • 2015 ACR/ARHP Annual Meeting
Correlation of Scleroderma Interstitial Lung Disease with Gastroesophageal Reflux
Brady Bulian¹, W Leroy Griffing² and Michael Crowell³, ¹Internal Medicine, Mayo Clinic Arizona, Scottsdale, AZ, ²Rheumatology, Mayo Clinic Arizona, Scottsdale, AZ, ³Gastroenterology, Mayo Clinic Arizona, Scottsdale, AZ
Background/Purpose: Systemic sclerosis (SSc) is a connective tissue disease involving the skin and visceral organs, most commonly the gastrointestinal tract and lungs. Interstitial lung disease…
Abstract Number: 1896 • 2015 ACR/ARHP Annual Meeting
Early Signs, Symptoms and Auto-Antibodies to Predict Diffuse Cutaneous or Limited Cutaneous Systemic Sclerosis at First Presentation
WMT van den Hombergh¹, HKA Knaapen-Hans¹, Patricia E. Carreira^2,3, FHJ van den Hoogen¹, Jaap Fransen¹ and MC Vonk¹, ¹Rheumatology, Radboud University Medical Centre, Nijmegen, Netherlands, ²Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, ³Rheumatology Unit, Hospital 12 de Octubre, Hospital 12 de Octubre, Madrid, Spain
ABSTRACT Background/Purpose: Diffuse cutaneous systemic sclerosis (dcSSc) is associated with a poorer prognosis compared to limited cutaneous SSc (lcSSc), due to earlier and more severe…
Abstract Number: 1897 • 2015 ACR/ARHP Annual Meeting
Fragmented Qrs Patterns Do Not Correlate with the Degree of Lung and Skin Involvement in Patients with Systemic Sclerosis
Didem Uzunaslan¹, Caner Saygin¹, Mehmet Kostek², Mehmet Ozdemir², Tufan Torun², Servet Altay³ and Gulen Hatemi⁴, ¹Cleveland Clinic, Cleveland, OH, ²Istanbul University, Cerrahpasa Faculty of Medicine, Istanbul, Turkey, ³Edirne Community Hospital, Edirne, Turkey, ⁴Rheumatology, Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey
Background/Purpose: Cardiac involvement is a common subclinical feature of systemic sclerosis (SSc) and results from the widespread fibrosis observed during disease course. Fragmented QRS (fQRS)…
Abstract Number: 1898 • 2015 ACR/ARHP Annual Meeting
Are There Risk Factors for Calcinosis in Scleroderma?
Sneha Pai¹ and Vivien Hsu², ¹Rheumatology, Robert Wood Johnson Medical School Hospital, New Brunswick, NJ, ²Medicine, Rutgers University, New Brunswick, NJ
Background/Purpose: Calcinosis is the deposition of calcium hydroxyapatite in the soft tissues in patients with scleroderma spectrum disorders (SSc). Risk factors are unknown and there…
Abstract Number: 1899 • 2015 ACR/ARHP Annual Meeting
Aortic Stenosis Is Increased in Systemic Sclerosis Patients with Pulmonary Arterial Hypertension Compared to Other Forms of Pulmonary Arterial Hypertension
María Martín López¹, Otto Martin Olivas Vergara², Mario Rodríguez³, Carmen D Merino⁴, Carmen Jiménez^5,6, Estibaliz Loza⁷, Pilar Escribano^5,6, Loreto Carmona⁸ and Patricia E. Carreira², ¹RHEUMATOLOGY, Hospital Universitario 12 de Octubre, Madrid, Spain, ²Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, ³Hospital Universitario 12 de Octubre, Madrid, Spain, ⁴Fundación Hospital de Alcorcón, Madrid, Spain, ⁵Cardiology Department, Hospital Universitario 12 de Octubre, Madrid, Spain, ⁶Multidisciplinary Pulmonary Hypertension Unit. Hospital Universitario 12 de Octubre, Madrid, Spain, ⁷Research Unit. Sociedad Española de Reumatología, Madrid, Spain, ⁸Instituto de Salud Musculoesquelética, Madrid, Spain
Background/Purpose: Degenerative aortic stenosis (DAS) is the most common form of valvular heart disease associated with advancing age. DAS pathophysiology has not been clearly elucidated,…
Abstract Number: 1900 • 2015 ACR/ARHP Annual Meeting
Performance of the Detect Protocol for Pulmonary Arterial Detection in Systemic Sclerosis Patients in Clinical Practice
Otto Martin Olivas Vergara¹, Beatriz E. Joven¹, Belen Diaz Anton², Carmen Jiménez², Maria Martin Lopez³, Pilar Escribano² and Patricia E. Carreira^1,2, ¹Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, ²Multidisciplinary Pulmonary Hypertension Unit. Hospital Universitario 12 de Octubre, Madrid, Spain, ³RHEUMATOLOGY, Hospital Universitario 12 de Octubre, Madrid, Spain
Background/Purpose: To analyze the usefulness of the DETECT protocol (1) for the prediction of pulmonary hypertension (PH) and pulmonary arterial hypertension (PAH) in routine clinical…
Abstract Number: 1901 • 2015 ACR/ARHP Annual Meeting
Association of Serum Adipokines Adipsin, Adiponectin, and Leptin/Adiponectin Ratio with Systemic Sclerosis
Benjamin Korman¹, Roberta Goncalves Marangoni¹, Monique E. Hinchcliff², Sanjiv Shah³, Mary A. Carns⁴, Rosalind Ramsey-Goldman⁵ and John Varga⁶, ¹Division of Rheumatology, Northwestern University, Chicago, IL, ²Division of Rheumatology, Division of Rheumatology, Northwestern University, Feinberg School of Medicine, Chicago, IL, ³Northwestern University, Chicago, IL, ⁴Rheumatology, Northwestern University, Chicago, IL, ⁵Northwestern University Feinberg School of Medicine, Chicago, IL, ⁶Division of Rheumatology, Northwestern University, Feinberg School of Medicine, Chicago, IL
Background/Purpose: Patients with systemic sclerosis (SSc) display reductions in adipose tissue, particularly intradermal adipose tissue. There are currently no well-validated serum biomarkers in SSc, and…
Abstract Number: 1902 • 2015 ACR/ARHP Annual Meeting
Systemic Sclerosis and Lung Cancer Risk: Data from the Canadian Scleroderma Research Group
Lama Sakr¹, Elie Younanian², Marie Hudson³, Mianbo Wang⁴, Murray Baron⁵ and Sasha Bernatsky⁶, ¹Division of Pulmonary Diseases, Jewish General Hospital, Montreal, QC, Canada, ²Division of Pulmonary Diseases, McGill University, Montreal, QC, Canada, ³McGill University, Jewish General Hospital, Montreal, QC, Canada, ⁴Lady Davis Institute for Medical Research, Montreal, QC, Canada, ⁵Jewish General Hospital, Lady Davis Institute and McGill University, Montreal, QC, Canada, ⁶Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada
Background/Purpose: The literature supports an increased incidence of certain malignancies in patients with systemic sclerosis (SSc), including lung cancers. Predictors of lung cancer in SSc…
Abstract Number: 1903 • 2015 ACR/ARHP Annual Meeting
Assessment of Subclinical Atherosclerosis in Patients with Systemic Sclerosis: Results from a Multicentric Cohort
Codrina Ancuta^1,2, Codruta Belibou³, Cristina Pomirleanu^1,4, Carina Mihai⁵, Ioan Ancuta⁵, Patricia E. Carreira⁶, Jose Luis Rosales Alexander⁷, Juan José Alegre⁸, Valeria Riccieri⁹, Maria J. Salvador¹⁰ and Rodica Chirieac⁴, ¹Rheumatology, Gr.T.Popa University of Medicine and Pharmacy, Iasi, Romania, ²Rheumatology 2, Clinical Rehablitation Hospital, Iasi, Romania, ³Research Department, Clinical Rehabilitation Hospital, Iasi, Romania, ⁴Rheumatology 2, Clinical Rehabilitation Hospital, Iasi, Romania, ⁵Department of Internal Medicine and Rheumatology, Dr.I.Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, ⁶Multidisciplinary Pulmonary Hypertension Unit. Hospital Universitario 12 de Octubre, Madrid, Spain, ⁷Rheumatology, Hospiten Health Network, Tenerife, Spain, ⁸Rheumatology Department, Hospital Universitario Doctor Peset, Valencia, Spain, ⁹Cattedra di Reumatologia, Dip Clinica e Terapia Medica, Sapienza Università di Roma, Roma, Italy, ¹⁰Rheumatology, Centro Hospitalar e Universitário de Coimbra - Hospitais da Universidade de Coimbra, EPE, Coimbra, Portugal
Background/Purpose: Although numerous studies have reported different findings on subclinical and definite atherosclerosis (AS) in autoimmune rheumatic diseases, data in systemic sclerosis (SSc) are still…
Abstract Number: 1904 • 2015 ACR/ARHP Annual Meeting
Development of the Mawdsley Calcinosis Questionnaire (MCQ) Version 1 – a Patient-Reported Outcome Measure (PROM) for Systemic Sclerosis Related Calcinosis (SSc-Ca)
Lesley Ann Saketkoo¹, Kim Fligelstone², Evan Busman³, Angela Christensen⁴, Sophia Cenac⁵, Samara Khalique⁶, Andrew Aubin⁷, Veronika K. Jaeger⁸, Anne Mawdsley⁹, Jessica K. Gordon¹⁰, Randi Kaufman¹¹, Murray Baron¹², Virginia D. Steen¹³ and Tracy M. Frech¹⁴, ¹Tulane University Lung Center, New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, LA, ²Royal Free Hospital, Scleroderma Unit and Scleroderma Society, London, United Kingdom, ³Atlanta Scleroderma Support Group, Atlanta, GA, ⁴Tulane University School of Medicine, New Orleans, LA, ⁵Louisiana State University Health Science Center, New Orleans, LA, ⁶Louisiana State University Health Sciences Center, New Orleans, LA, ⁷Louisiana State University School of Medicine, New Orleans, LA, ⁸Department of Rheumatology, University Hospital Basel, Basel, Switzerland, ⁹Raynaud's & Scleroderma - Care and Support UK, Cheshire, United Kingdom, ¹⁰Rheumatology, Hospital for Special Surgery, New York, NY, ¹¹Lousiana State University Health Sciences Center - School of Public Health, New Orleans, LA, ¹²Jewish General Hospital, Lady Davis Institute and McGill University, Montreal, QC, Canada, ¹³Rheumatology, Georgetown University Medical Center, Washington, DC, ¹⁴Div of Rheumatology, University of Utah, Salt Lake City, UT
Background/Purpose: SSc-Ca is a poorly understood vascular complication of SSc that usually related to extreme constant pain and infection/amputation risk for persons living with SSc-Ca…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].